GlucoTrack, Inc.
GCTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $9 | $11 | $8 | $14 |
| Gross Profit | -$9 | -$11 | -$8 | -$14 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,165 | $3,150 | $1,871 | $1,699 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,135 | $1,635 | $1,619 | $2,141 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4,300 | $4,785 | $3,490 | $3,840 |
| Operating Income | -$4,309 | -$4,796 | -$3,498 | -$3,854 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $138 | $40 | -$3,335 | -$6,240 |
| Pre-Tax Income | -$4,171 | -$4,756 | -$6,833 | -$10,094 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,171 | -$4,756 | -$6,833 | -$10,094 |
| % Margin | – | – | – | – |
| EPS | 4.64 | -9.62 | -0.67 | -21.75 |
| % Growth | 148.2% | -1,335.8% | 96.9% | – |
| EPS Diluted | 4.64 | -9.62 | -0.67 | -21.75 |
| Weighted Avg Shares Out | 899 | 495 | 372 | 330 |
| Weighted Avg Shares Out Dil | 899 | 495 | 372 | 330 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $29 | $37 | $1,239 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $9 | $11 | $8 | $14 |
| EBITDA | -$4,162 | -$4,745 | -$6,825 | -$10,080 |
| % Margin | – | – | – | – |